English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

In New York v. Actavis, the Second Circuit’s ruling forbids product hopping, or extending the monopoly of a patented drug by introducing a new formulation of the drug and discontinuing an older one, if there is evidence that the strategy is coercive and used to restrict fair competition.

A Legal Test for the Pharmaceutical Company Practice of “Product Hopping”